Progression to Disability Milestones in Multiple Sclerosis with Long-Term Natalizumab Treatment

Maria Trojano,Helmut Butzkueven, Ludwig Kappos, Heinz Wiendl, Tim Spelman, Fabio Pellegrini, Fabio Pellegrini, Qunming Dong, Harold Köndgen, Shibeshih Belachew